| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.002 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.005 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.005 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |